Company intelligence / Profile preview

NeuroPace

Mountain View, California, United Statesneuropace.com ↗

Ownership: Public · NPCE
Development stage: Commercial

Overview

NeuroPace’s RNS System has demonstrated significant and sustained reduction in seizure frequency for patients with drug-resistant focal epilepsy. Long-term clinical studies show enduring improvements in quality of life and cognition with no stimulation-related side effects. The system received FDA approval for adults in 2013 and expanded to pediatric use (age 9+) in 2022. Ongoing pivotal studies are evaluating its use for additional indications such as idiopathic generalized epilepsy and Lennox-Gastaut Syndrome

Therapeutic areas: Neurology
Modalities: DeviceNeuromodulation
Industry: Implantable Medical Devices

Drug pipeline

1 asset

RNS System

Commercial

Indications: Drug-resistant focal epilepsy

Partnerships

Strategic collaboration announced December 2023 with a clinical-stage biotechnology company to leverage the data capabilities of the RNS system; details on partner not disclosed

Financials

Market cap: $503.2M
Total revenue: $22.8M
Enterprise value: $521.5M

Beyond the preview

Go deeper on NeuroPace.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NeuroPace.

Explore the full profile